Ifp Advisors, Inc Cyma Bay Therapeutics, Inc. Transaction History
Ifp Advisors, Inc
- $2.05 Billion
- Q4 2023
A detailed history of Ifp Advisors, Inc transactions in Cyma Bay Therapeutics, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 650 shares of CBAY stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
650
Previous 650
-0.0%
Holding current value
$0
Previous $9,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CBAY
# of Institutions
11Shares Held
1.88MCall Options Held
0Put Options Held
0-
Foresite Capital Management Iii, LLC Larkspur, CA1.64MShares$015.17% of portfolio
-
Abingworth LLP London, X0131KShares$00.27% of portfolio
-
Golden State Equity Partners South Coast Metro, CA54.3KShares$00.32% of portfolio
-
Connacht Asset Management LP New York, NY12KShares$01.09% of portfolio
-
Ctc Capital Management, LLC10.7KShares$00.2% of portfolio
About CymaBay Therapeutics, Inc.
- Ticker CBAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,677,904
- Description
- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...